维普中文期刊产品整合服务
20篇 您的检索式:作者名="Motolese"
    题名 作者 年代 出处 被引量
1Determinants of stock market volatility and risk premia显示文摘Mordecai Kurz Hehui Jin Maurizio Motolese 2005Annals of Finance2005,,2:1
2Preven tion of sudden cardiac death after a first myocardial infarction by pharmacologic or surgical antiadrenergic interventions显示文摘SCHWARTZ P J MOTOLESE M POLLAVINI G 1992J Cardiovase Electrophysiol1992,3,:1
3Endogenous uncertainty and market volatility显示文摘Mordecai Kurz Maurizio Motolese 2001Economic Theory2001,,3:1
4Prevention of sudden cardiac death after a first myocardial infarction by pharmacologic or surgical antiadrenergic interventions显示文摘Schwartz PJ Motolese M Pollavini G 1992J Cardiovasc Electrophysiol1992,3,:1
5Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus显示文摘L. Epifano A. Vincenzo C. Fanelli E. Porcellati G. Perriello P. Feo M. Motolese P. Brunetti Dr. G. B. Bolli 1992European Journal of Clinical Pharmacology1992,,3:1
6Recurrence rateusing fibrin glue assisted ipsilateral conjunctival autograft in pterygium surgery: 2-year follow-up 显示文摘Sarnicola V Vannozzi L Motolese PA 2010Cornea2010,29,:1
7Longterm follow-up of diode laser transscleral cyclophotocoagulation in the treatment of refractory glaucoma 显示文摘Frezzotti P Mittica V Martone G Motolese I Lomurno L Peruzzi S 2010Acta Ophthalmol2010,88,1:1
8Effect of evening versus morning benazepril on 24-hour blood pressure:a comparative study with continuous intraarterial monitoring显示文摘Palatini P Mos L Motolese M 1993Int J Clin Pharmacol Ther Toxicol1993,31,6:1
9Recurrence rate using fibrin glue-assisted ipsilateral conjunctival autograt in pterygium surgery: 2-year follow-up显示文摘Sarnicola V Varmozzi L Motolese PA 2010Comea2010,29,11:1
10Ocular manifestations of chronic graft-versus-host disease in patients treated with extra corporeal photochemotherapy 显示文摘Motolese E Rubegnic P Poqqiali S 2007Eur J Ophthalmol2007,17,6:1
11Effects of benazepril on stress testing blood pressure in essential hypertension显示文摘 Mores N Motolese M 1994Am J Cardiol1994,73,:1
12Cell composition and immunohistochemical detection of VEGF, TGF - beta, and TNF - alpha in proliferative vitreoretinopathy显示文摘Toti P Greco G Motolese E 2012Journal of Submicroscopic Cytology & Pathology2012,95,8:1
13Recurrence rate u- sing fibrin glue-assisted ipsilateial conjunctival autograft in pterygium surgery :2-year follow-up 显示文摘Sarnicola V Vannozzi L Motolese PA 2010Cornea2010,29,11:1
14Longterm follow-up of diode laser transscleral cyclo-photocoagulation in the treatment of refractory glaucoma 显示文摘Frezzotti P Mittica V Martone G Motolese I Lomumo L Peruz-zi S 2010Acta Ophthalmol2010,,1:1
15Valsartan,a new angiotensin Ⅱ antagonist: tolerability and effects on renal function in patients with renovascular arterial hypertension显示文摘 Favilla S Motolese M 1997J Am Soc Nephrol1997,8,184:1
16Longterm follow-up of diode laser transscleral cyclo-photocoagulation in the treatment of refractory glaucoma显示文摘Frezzotti P Mittica V Martone G Motolese I Lomurno L Peruz-zi S 2010Acta Ophthalm ol2010,88,1:1
17An In Vivo Confocal Microscopy Analysis of Effects of Topical Antiglaucoma Therapy With Preservative on Corneal Innervation and Morphology显示文摘Gianluca Martone Paolo Frezzotti Gian Marco Tosi Claudio Traversi Vincenzo Mittica Alex Malandrini Patrizia Pichierri Angelo Balestrazzi Paolo Alfonso Motolese Ilaria Motolese Edoardo Motolese 2009American Journal of Ophthalmology2009,,4:1
18Prevention of sudden cardiac death after a first myocardial infarction by pharmacologic or surgical antiadrenergie interventions 显示文摘Schwartz PJ Motolese M Pollavini G 1992J Cardiovasc Electro- physiol1992,3,1:1
19Effectiveness of platelet- rich plasma in healing necrobiosis lipoidica diabeticorum ulcers 显示文摘Motolese A Vignati F Antelmi A 2015Clin Exp Dermatol2015,40,1:1
20Safety,immunogenicity,efficacy,and acceptability of COVID-19 vaccination in people with multiple sclerosis:a narrative review显示文摘In the last two years,a new seve re acute res piratory syndrome coronavirus(SARS-CoV)infection has spread worldwide leading to the death of millions.Va ccination represents the key factor in the global strategy against this pandemic,but it also poses several problems,especially for vulnerable people such as patients with multiple scle rosis.In this review,we have briefly summarized the main findings of the safety,efficacy,and acceptability of Coronavirus Disease 2019(COVID-19)vaccination fo r multiple sclerosis patients.Although the acceptability of COVID-19 vaccines has progressively increased in the last year,a small but significant part of patients with multiple sclerosis still has relevant concerns about vaccination that make them hesitant about receiving the COVID-19 vaccine.Overall,available data suggest that the COVID-19 vaccination is safe and effective in multiple scle rosis patients,even though some pharmacological treatments such as anti-CD20 therapies or sphingosine I-phosphate receptor modulato rs can reduce the immune response to vaccination.Accordingly,COVID-19 vaccination should be strongly recommended for people with multiple scle rosis and,in patients treated with anti-CD20 therapies and sphingosine I-phosphate receptor modulato rs,and clinicians should evaluate the appropriate timing for vaccine administration.Further studies are necessary to understand the role of cellular immunity in COVID-19 vaccination and the possible usefulness of booster jabs.On the other hand,it is mandatory to learn more about the reasons why people refuse vaccination.This would help to design a more effective communication campaign aimed at increasing vaccination coverage among vulnerable people.Fioravante Capone Mariagrazia Rossi Alessandro Cruciani Francesco Motolese Fabio Pilato Vincenzo Di Lazzaro 2023Neural Regeneration Research2023,18,2:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费